Huge global trial was halted after a single participant showed a possible adverse reaction, but the U.K.’s independent safety regulator cleared it to resume. Source

JOIN NCOV.LINK NEWSLETTER

And get notified everytime we publish a new Important announcements. We will not email you often, unless there are important things that need to get in touch with you, such as added new tools or new domain names.